FDA Inspection 1015882 — Dorado Health Inc
The FDA completed an inspection of Dorado Health Inc on June 15, 2017 in Manati, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Manati, PR (United States)